DE69622391T2 - Missbrauch sichtbar machende pharmazeutische dosisform - Google Patents

Missbrauch sichtbar machende pharmazeutische dosisform

Info

Publication number
DE69622391T2
DE69622391T2 DE69622391T DE69622391T DE69622391T2 DE 69622391 T2 DE69622391 T2 DE 69622391T2 DE 69622391 T DE69622391 T DE 69622391T DE 69622391 T DE69622391 T DE 69622391T DE 69622391 T2 DE69622391 T2 DE 69622391T2
Authority
DE
Germany
Prior art keywords
abuse
pharmaceutical dosage
making pharmaceutical
visible making
visible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69622391T
Other languages
English (en)
Other versions
DE69622391D1 (de
Inventor
Keith Tanner
Kelly Orange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Application granted granted Critical
Publication of DE69622391D1 publication Critical patent/DE69622391D1/de
Publication of DE69622391T2 publication Critical patent/DE69622391T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69622391T 1995-04-26 1996-04-25 Missbrauch sichtbar machende pharmazeutische dosisform Expired - Lifetime DE69622391T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/427,895 US5624681A (en) 1995-04-26 1995-04-26 Tamper evident pharmaceutical dosage form
PCT/US1996/005891 WO1996033702A1 (en) 1995-04-26 1996-04-25 Tamper evident pharmaceutical dosage form

Publications (2)

Publication Number Publication Date
DE69622391D1 DE69622391D1 (de) 2002-08-22
DE69622391T2 true DE69622391T2 (de) 2003-02-13

Family

ID=23696747

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69622391T Expired - Lifetime DE69622391T2 (de) 1995-04-26 1996-04-25 Missbrauch sichtbar machende pharmazeutische dosisform

Country Status (7)

Country Link
US (1) US5624681A (de)
EP (1) EP0822810B1 (de)
JP (1) JP4474507B2 (de)
AU (1) AU5630596A (de)
CA (1) CA2219289C (de)
DE (1) DE69622391T2 (de)
WO (1) WO1996033702A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363982A (en) * 2000-06-26 2002-01-16 Mw Encap Ltd Tamper-proof capsules
PT1424973E (pt) * 2001-04-23 2010-06-02 Euro Celtique Sa Sistema de eliminação para uma forma de dosagem transdérmica
WO2003015531A2 (en) * 2001-08-06 2003-02-27 Thomas Gruber Pharmaceutical formulation containing dye
US20050163833A1 (en) * 2001-10-23 2005-07-28 Rolf Muller Production of starch-gel-based shaped bodies
US7169450B2 (en) * 2002-05-15 2007-01-30 Mcneil-Ppc, Inc. Enrobed core
US6946156B2 (en) * 2002-05-15 2005-09-20 Mcneil-Ppc, Inc. Process for enrobing a core
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
US20070160688A1 (en) * 2006-01-10 2007-07-12 Eric Marchewitz Use of flavonoids to increase blood serum levels of dehydroepiandrosterone
US20070281008A1 (en) * 2006-06-05 2007-12-06 Lin Shun Y Personal lubricant compositions and kits for providing personal lubrication
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
US20110171281A1 (en) * 2010-01-14 2011-07-14 Karl Wei Cao Soft capsule composition and method of use
EP3246000A1 (de) * 2016-05-18 2017-11-22 Capsugel Belgium NV Trennbare kapsel für sprenkleranwendungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844906A (en) * 1987-03-25 1989-07-04 Kv Pharmaceutical Company Tamper evident pharmaceutical capsule
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
MY111346A (en) * 1993-07-09 1999-11-30 Smithkline Beecham Corp Soft-shelled gelatin encapsulated particles

Also Published As

Publication number Publication date
WO1996033702A1 (en) 1996-10-31
CA2219289A1 (en) 1996-10-31
EP0822810B1 (de) 2002-07-17
JP4474507B2 (ja) 2010-06-09
US5624681A (en) 1997-04-29
AU5630596A (en) 1996-11-18
JPH11504336A (ja) 1999-04-20
DE69622391D1 (de) 2002-08-22
EP0822810A1 (de) 1998-02-11
CA2219289C (en) 2003-01-28

Similar Documents

Publication Publication Date Title
DE122005000024I2 (de) Darifenacin enthaltende Pharmazeutische zuberreitungen
DE69525148D1 (de) Pharmazeutische formulierung
ATE312602T1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
DE69615887T2 (de) Oral anzuwendende Arzneizubereitung enthaltend Olanzapin
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
ATA129892A (de) Pharmazeutische zusammensetzung
EE04293B1 (et) Stabiilsed lüofiliseeritud ravimvormid
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
NO981008D0 (no) Farmasöytisk formulering
DE59915033D1 (de) Pharmazeutische Zubereitung
ZA983169B (en) Pharmaceutical dosage units
DE69622391T2 (de) Missbrauch sichtbar machende pharmazeutische dosisform
DE4294862T1 (de) Pharmazeutische Komposition
DE69614407T2 (de) Pharmazeutische zusammensetzungen
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE59310248D1 (de) Pharmazeutische Zubereitung auf Gestagen-Basis
DE69632787D1 (de) Pharmazeutische pellets
FI973230A (fi) Uusi farmaseuttinen formulaatio
DK0818964T3 (da) Doseringsstift
DE19681529D2 (de) Pharmazeutische Darreichungsform
DE69613966T2 (de) Pharmazeutische zusammensetzungen mit pektin
NO942228D0 (no) Ipsapiron-legemiddeltilberedning
BR9603673A (pt) Preparado de combinação farmacêutica compreendendo cetoprofeno
ATA77096A (de) Pharmazeutische präparation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition